Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian First Nations cohort.

Braun K, Larcombe L, Orr P, Nickerson P, Wolfe J, Sharma M.

PLoS One. 2013 Jul 4;8(7):e67842. doi: 10.1371/journal.pone.0067842. Print 2013.

2.

Killer cell immunoglobulin like receptor gene association with tuberculosis.

Pydi SS, Sunder SR, Venkatasubramanian S, Kovvali S, Jonnalagada S, Valluri VL.

Hum Immunol. 2013 Jan;74(1):85-92. doi: 10.1016/j.humimm.2012.10.006. Epub 2012 Oct 13.

PMID:
23073291
3.

[KIR-HLA class i and pulmonary tuberculosis in the Amerindian population in Chaco, Argentina].

Habegger de Sorrentino A, Pardo R, Marinic K, Duarte SC, Lotero C.

Enferm Infecc Microbiol Clin. 2014 Nov;32(9):565-9. doi: 10.1016/j.eimc.2013.10.007. Epub 2013 Dec 12. Spanish.

PMID:
24332713
4.
5.

The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas.

Rempel JD, Hawkins K, Lande E, Nickerson P.

Eur J Hum Genet. 2011 Dec;19(12):1276-80. doi: 10.1038/ejhg.2011.114. Epub 2011 Jul 6.

6.

Characterization of Killer cell immunoglobulin-like receptor (KIR) genotypes and haplotypes in Chinese Han population.

Bao X, Wang M, Zhou H, Wu X, Yang L, Xu C, Yuan X, Zhang J, Li L, Wu D, He J.

Tissue Antigens. 2013 Nov;82(5):327-37. doi: 10.1111/tan.12211.

PMID:
24131019
7.

Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.

Tajik N, Shah-hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, Farnia P, Jalali A.

Tissue Antigens. 2012 Feb;79(2):90-6. doi: 10.1111/j.1399-0039.2011.01812.x. Epub 2011 Nov 30.

PMID:
22128749
8.

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Symons HJ, Leffell MS, Rossiter ND, Zahurak M, Jones RJ, Fuchs EJ.

Biol Blood Marrow Transplant. 2010 Apr;16(4):533-42. doi: 10.1016/j.bbmt.2009.11.022. Epub 2009 Dec 2.

9.

Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.

Vierra-Green C, Roe D, Hou L, Hurley CK, Rajalingam R, Reed E, Lebedeva T, Yu N, Stewart M, Noreen H, Hollenbach JA, Guethlein LA, Wang T, Spellman S, Maiers M.

PLoS One. 2012;7(11):e47491. doi: 10.1371/journal.pone.0047491. Epub 2012 Nov 5.

10.

Killer cell immunoglobulin-like receptor (KIR) locus profiles in the Tunisian population.

Meriem B, Jihen S, Houda K, Ghaya C, Manel C, Hedi B, Slama H.

Hum Immunol. 2015 May;76(5):355-61. doi: 10.1016/j.humimm.2015.03.002. Epub 2015 Mar 19.

PMID:
25797201
11.

Killer cell immunoglobulin-like receptor genotypes and haplotypes with susceptibility to pulmonary tuberculosis infection.

Lu C, Bai XL, Deng YF, Wang CY, Fan G, Shen YJ, Liu YQ, Zhang BC, Zhao YR, Huan C, Zhang CZ, Lu ZM.

Clin Lab. 2014;60(5):821-5.

PMID:
24839826
12.
13.

Activating KIRs alter susceptibility to pulmonary tuberculosis in a South African population.

Salie M, Daya M, Möller M, Hoal EG.

Tuberculosis (Edinb). 2015 Dec;95(6):817-821. doi: 10.1016/j.tube.2015.09.003. Epub 2015 Oct 17.

PMID:
26542219
14.

Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation.

Stern M, Hadaya K, Hönger G, Martin PY, Steiger J, Hess C, Villard J.

Am J Transplant. 2011 Jun;11(6):1302-7. doi: 10.1111/j.1600-6143.2011.03516.x. Epub 2011 Apr 12.

15.

Characterization of human killer immunoglobulin-like receptors (KIRs) among healthy Saudis.

Osman AE, Mubasher M, ElSheikh NE, AlHarthi H, Al Yami AS, Rajalingam R, Al-Dehaimi A, Middleton D, ElGhazali G.

Hum Immunol. 2014 Jun;75(6):536-40. doi: 10.1016/j.humimm.2014.02.023. Epub 2014 Mar 6.

16.

Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.

Kuśnierczyk P, Mozer-Lisewska I, Zwolińska K, Kowala-Piaskowska AE, Bura M, Bereszyńska I, Pauli A, Żeromski J.

Hum Immunol. 2015 Mar;76(2-3):102-8. doi: 10.1016/j.humimm.2015.01.020. Epub 2015 Jan 27.

PMID:
25636579
17.

KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.

Portela P, Merzoni J, Lindenau JD, Damin DC, Wilson TJ, Roesler R, Schwartsmann G, Jobim LF, Jobim M.

Hum Immunol. 2017 Mar;78(3):263-268. doi: 10.1016/j.humimm.2017.01.003. Epub 2017 Jan 11.

PMID:
28088355
18.
19.

Diversity in KIR gene repertoire in HIV-1 exposed infected and uninfected infants: A study from India.

Chavan VR, Ahir S, Ansari Z, Samant-Mawani P, Nanavati R, Mehta P, Mania-Pramanik J.

J Med Virol. 2016 Mar;88(3):417-25. doi: 10.1002/jmv.24348. Epub 2015 Aug 24.

PMID:
26255774
20.

Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.

López-Hernández R, Campillo JA, Legaz I, Valdés M, Salama H, Boix F, Hernández-Martínez AM, Eguia J, González-Martínez G, Moya-Quiles MR, Minguela A, García-Alonso A, Carballo F, Muro M.

Microbiol Immunol. 2016 Nov;60(11):787-792. doi: 10.1111/1348-0421.12447.

PMID:
27797112

Supplemental Content

Support Center